BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 18, 2019
View Archived Issues
Roche presents first-in-human data for RO-7062931
Read More
HPN-328 targeting DLL3 shows preclinical efficacy and safety for immunotherapy in SCLC
Read More
New Smo antagonist shows antitumor activity in medulloblastoma and cholangiocarcinoma animal models
Read More
New PEGylated IL-2 with improved pharmacologic properties specifically activates and expands Tregs
Read More
Anchiano discontinues phase II Codex study of inodiftagene vixteplasmid in NMIBC
Read More
Positive results presented from second phase III psoriasis study of bimekizumab
Read More
Results presented from proof-of-concept phase I study of cenerimod
Read More
First-in-human data presented for tetrameric bispecific antibody AK-104
Read More
DRA inhibitors synthesized for cystic fibrosis-related nephrolithiasis
Read More
Gut bacteria can drive heart autoimmunity
Read More
Succinate identified as novel cancer therapy target
Read More
Sparsentan does not appear to have a negative effect on quality of life in FSGS patients
Read More
First-in-human data for novel platelet glycoprotein IIb/IIIa inhibitor RUC-4 in patients with STEMI
Read More
Institute for Translational Vaccinology tests RSV vaccine in phase I study
Read More
Japanese researchers patent TRPC3 and TRPC6 antagonists
Read More
Nippon Chemiphar discloses xanthine oxidase inhibitors
Read More
Innate Tumor Immunity identifies NLRP3 agonists
Read More
Korean investigators disclose mTORC1 inhibitors
Read More
New SCD1 and SCD5 inhibitors presented by Yumanity Therapeutics
Read More
Phase I trial studies Rocket's hematopoietic cell-based gene therapy for pyruvate kinase deficiency
Read More
Shanghai De Novo studies DN-1508052-01 in phase I for advanced solid tumors
Read More
FDA approves Adakveo to reduce vaso-occlusive crises in patients with sickle cell disease
Read More